Neurology and Neurosurgery

91-105 of 114

• 

  RestartResume

  Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role

  MinuteCE®

  Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role

  • 

    

    Vera Bril, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management

  MinuteCE®

  Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management

  • 

    

    Vera Bril, MD

  • 

    

    Hans Katzberg, MD

  1.00 program credits

• 

  RestartResume

  Managing Side Effects in FcRn Therapy: Best Practices for gMG

  MinuteCE®

  Managing Side Effects in FcRn Therapy: Best Practices for gMG

  • 

    

    Vera Bril, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Preventing Myasthenic Crisis: Early Signs and Critical Interventions

  MinuteCE®

  Preventing Myasthenic Crisis: Early Signs and Critical Interventions

  • 

    

    Vera Bril, MD

  • 

    

    Hans Katzberg, MD

  1.00 program credits

• 

  RestartResume

  Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF 

  CME/CE Broadcast Replay

  Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF 

  • 

    

    M. Edip Gurol, MD, MSc

  • 

    

    Robin Novakovic, MD

  • 

    

    Shadi Yaghi, MD

  • 

    

    Jeffrey Weitz, MD

  1.50 credits

• 

  RestartResume

  The Safety of Sodium Oxybate in Treating Narcolepsy

  CME/CE

  The Safety of Sodium Oxybate in Treating Narcolepsy

  • 

    

    Clete A. Kushida, MD, PhD

  • 

    

    Sally Ibrahim, MD, FAAP

  0.50 credits
• advertisement

• 

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  MinuteCE®

  Decoding CIDP: Exploring Common and Atypical Variants

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  MinuteCE®

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credits

• 

  MinuteCE®

  Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 credits 10 episodes

• 

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  MinuteCE®

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  MinuteCE®

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits
• advertisement

• 

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  MinuteCE®

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• 

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  MinuteCE®

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credits

• Prev
• 1
• 2
• …
• 5
• 6
• 7
• 8
• Next